CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 4

Industry reads hand-picked by our editors

Nov 12, 2025

STAT
How two top FDA officials are quietly upending vaccine regulations
The Boston Globe
Vertex’s CEO was an AI skeptic. But not anymore.
Fierce Biotech
With Summit leading the pack in PD-1xVEGF bispecifics, Pfizer lays out its own plan to replace Keytruda

Nov 10, 2025

Nature
DNA pioneer James Watson has died ― colleagues wrestle with his legacy
KFF Health News
Shutdown Has Highlighted Washington’s Retreat From Big Ideas on Health Care
Reuters
Pfizer’s obesity win is new formula for pharma M&A

Nov 07, 2025

The Wall Street Journal
This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed.
Regulatory Affairs Professional Society
Makary says FDA is ‘strong’ despite recent leadership turmoil
MIT Technology Review
Cloning isn’t just for celebrity pets like Tom Brady’s dog

Nov 06, 2025

The New York Times
The Flawed Technology Behind America’s High C-Section Rate
Bloomberg
AstraZeneca Profit Beats Estimates on Cancer, Diabetes Drugs
Fierce Pharma
Teva CEO touts ‘defining strength’ of innovative drugs as its sales grow for 11th straight quarter
ApexOnco
Pfizer moves into the VEGF bispecific fast lane

Nov 05, 2025

Endpoints News
Lilly and Novo near White House deal on obesity drug prices
Science
U.K. science sector is ‘bleeding to death,’ lawmakers say in report
STAT
Arena BioWorks, an ambitious biomedical institute backed by billionaires, abruptly shuts down

Nov 04, 2025

Nature
‘Biotech Barbie’ says the time has come to consider CRISPR babies. Do scientists agree?
The Financial Times
Pfizer plays hardball in weight-loss drug fight
NPR
Searching ‘weight’ can bring up Ozempic in results. It’s a drug advertising loophole

Nov 03, 2025

Nature
Personalized gene editing helped one baby: can it be rolled out widely?
CNN
Science got peanut allergies all wrong – until the scientific method got it right
Reuters
BioNTech lifts 2025 revenue guidance on BMS partnership payment

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Playbook
Successful Biomarker-Driven Cancer Drug Development Custom content for Labcorp
Playbook
Design is Essential to Managing Clinical Trial Complexity Custom content for WCG
Playbook
CGT Approval and Reimbursement: All Stakeholder Perspectives Custom content for Cardinal Health

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

2026 Life Sciences AI & Data Predictions Webinar - on demand • Provided by Snowflake
Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.